Main Menu Main Content
The Whistleblower Blog

About This Blog

Presented by Hodgson Russ, the Whistleblower Blog is written by a team of lawyers experienced in successfully guiding both whistleblowers and companies accused by whistleblowers of wrongdoing through the False Claims Act process.

Whistleblower Lawsuit Costs GlaxoSmithKline $750 Million

By on

The Department of Justice (DOJ) has released its False Claims Act statistics for fiscal year 2010. According to this press release, the DOJ recovered $3 billion this year in False Claims Act recoveries, 83 percent, or $2.5 billion, of which involved health care fraud. The Obama Administration has made no secret of its focus on health care fraud, and health care companies have been in the news recently for getting caught up in false claims liability.

While the government made out pretty well this year, whistleblowers didn’t do too badly either, recovering $385 million. And one relator in particular has been in the news for her whistleblowing against one of the largest drug manufacturing companies in the world, GlaxoSmithKline, for one of the scariest health care frauds ever perpetrated. 

In October 2010, GlaxoSmithKline and one of its subsidiaries paid $750 million to settle False Claims Act liability stemming from the manufacturing of adulterated drugs at a plant in Puerto Rico. Read about the details here.

The relator in that case, Cheryl Eckard, was recently interviewed on CBS’s 60 Minutes. In her interview, Eckard talks about what she saw when she visited the plant: tainted water, unsanitary conditions, and, most egregiously, the mixing of different medicines. After the visit, Eckard took her findings to the vice president for quality and asked that he shut down the plant. He didn’t. After eight months of reporting problems at the plant, Eckard lost her job, and she turned over the information she had to the Food and Drug Administration and got a lawyer who brought a False Claims Act lawsuit. Eckard was awarded $96 million. Read about Eckard’s interview here.

Because of Eckard and whistleblowers like her, companies know that they have to take patient safety seriously, a benefit for everyone. Otherwise, they can end up with a catastrophic loss, myriad bad press, and loss of consumer trust—like GlaxoSmithKline.

Post a comment:

*All fields are required.

Attorney Advertising
Hodgson Russ LLP

Principal Address:
The Guaranty Building
140 Pearl Street, Suite 100
Buffalo, NY 14202
Tel: 716.856.4000
Stay Connected
RSS LinkedIn

About This Firm

Hodgson Russ is one of only a few major law firms that represents both whistleblowers and companies accused by whistleblowers of wrongdoing. This unusual perspective means we are exceptionally well positioned to advise whistleblowers about potential claims.

We are not a "whistleblower mill" that pays little attention to the needs of its clients or the factual nuances of complex cases. Rather, we are a team of highly experienced lawyers that selects only the best cases, affording us the time and focus to become fully immersed in the factual and legal details necessary to bring cases to successful resolution.